Adriamycin protocol

The Adriamycin protocol refers to a treatment plan that uses the chemotherapy drug doxorubicin (commonly known as Adriamycin) to fight cancer. This drug works by damaging cancer cells' DNA, preventing them from growing and dividing. The protocol typically involves scheduled intravenous doses over a set period, often combined with other therapies to improve effectiveness. While effective, it can cause side effects like hair loss, fatigue, and potential heart issues, so doctors monitor patients carefully throughout treatment. The goal is to maximize cancer cell destruction while managing risks to improve patient outcomes.